Frederick Manby
Vermögen: 33 Mio $ am 30.09.2026
Vermögen: 33 Mio $ am 30.09.2026
Dr. Frederick Manby is a Director & Chief Technology Officer at Iambic Therapeutics, Inc. He is on the Board of Directors at Iambic Therapeutics, Inc. Dr. Manby was previously employed as a Professor by University of Bristol.
He received his undergraduate degree from the University of York and a doctorate degree from the University of York.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.10.2026 | 1 730 465 ( 3,65 % ) | 33 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IAMBIC THERAPEUTICS, INC. | Gründer | 01.01.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.03.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of York
University of York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entos, Inc.
Entos, Inc. BiotechnologyHealth Technology Operates as a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen